1. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Issue 10304 (11th September 2021) Authors: Flaxman, Amy; Marchevsky, Natalie G; Jenkin, Daniel; Aboagye, Jeremy; Aley, Parvinder K; Angus, Brian; Belij-Rammerstorfer, Sandra; Bibi, Sagida; Bittaye, Mustapha; Cappuccini, Federica; Cicconi, Paola; Clutterbuck, Elizabeth A; Davies, Sophie; Dejnirattisai, Wanwisa; Dold, Christina; Ewer, Katie... Journal: Lancet Issue: Volume 398:Issue 10304(2021) Page Start: 981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial. Issue 10342 (11th June 2022) Authors: Li, Grace; Cappuccini, Federica; Marchevsky, Natalie G; Aley, Parvinder K; Aley, Robert; Anslow, Rachel; Bibi, Sagida; Cathie, Katrina; Clutterbuck, Elizabeth; Faust, Saul N; Feng, Shuo; Heath, Paul T; Kerridge, Simon; Lelliott, Alice; Mujadidi, Yama; Ng, Khuen Foong; Rhead, Sarah; Roberts, Hanna... Journal: Lancet Issue: Volume 399:Issue 10342(2022) Page Start: 2212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗